Global report - June 9, 2025
Lif: “The Council of Ministers’ compromise weakens the EU’s competitiveness”
The EU member states have agreed on a compromise for pharmaceutical legislation, which means, among other things, that the data protection period will remain unchanged at eight years.
Biotech Business - June 2, 2025
Bristol Myers Squibb receives European Commission approval for Opdivo
Opdivo is the first and only PD-1 inhibitor approved for subcutaneous (SC) use in the European Union.
Global report - May 13, 2025
Trump signs executive order directing the pharma industry to lower drug prices
On May 12, US President Trump signed an Executive Order to bring the prices Americans and taxpayers pay for prescription drugs in line with those paid by similar nations.
Event Highlights - May 13, 2025
From Insight to Impact: Highlights from Anglonordic’s 21st Edition
The Anglonordic Life Science Conference concluded its 21st edition at London’s historic County Hall on April 3rd, 2025. With over 350 registered delegates, the event celebrated over two decades of driving innovation and deepening collaboration across the UK, Nordic region, and Europe. More than ever before, this year showcased the power of cross-border partnerships and set the tone for an even more impactful future in the life sciences.
Global report - May 12, 2025
The US administration freezes new National Science Foundation awards
The policy prevents the NSF from awarding new research grants and from supplying allotted funds for existing grants, such as those that receive yearly increments of money.
Biotech Business - February 14, 2025
StemSight secures EUR 2.3 million in funding
The Finnish biotech company developing stem cell therapies for vision restoration, has raised funding from Voima Ventures, Finnish family offices (Stephen Industries Inc. & Biothom Oy), private investors, and Business Finland.
